Andrew Hedin
Partner·Bessemer Venture Partners
Cambridge, Massachusetts, United States
Andrew Hedin is a partner in Bessemer’s Cambridge office, investing across healthcare, including biotech therapeutics and software and services sold into healthcare verticals. Before joining Bessemer in 2015, he worked at F-Prime Capital investing in early-stage biotech and digital health, and at Leerink Partners advising biopharma companies. His portfolio highlights include Kymera Therapeutics, Peptone, Plenful and Seismic Therapeutic.
See the rest of Andrew Hedin's profile.
Deal history, investment focus, outreach angles and the rest of the background. One email, no password — we send a link and you land right back here.